Comprehensive analysis of Nippon India Nifty 500 Equal Weight Index Fund-Reg (G) (45043) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Nippon Life India Asset Management Ltd
The investment objective of the scheme is to provide investment returns that commensurate to the total returns of the securities as represented by the Nifty 500 Equal Weight Index before expenses, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be achieved.
A comprehensive at-a-glance view of key mutual fund health indicators
Moderate Returns
High Risk
Low Expense Ratio
Equity Focused
New Team
Below Average
Showing 1Y NAV history
Performance across different time periods
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Recent performance momentum
Outperformance vs benchmark
Market exposure level
Fund management costs
Risk-adjusted returns
Assets under management
Fund manager experience
Historical performance consistency
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Industry | % Assets |
|---|---|---|
| TREPS | Debt Others | 0.70% |
| TREPS | Debt Others | 0.36% |
| Syrma SGS Technology Ltd | Electronics | 0.28% |
| Anand Rathi Wealth Ltd | Finance | 0.26% |
| Laurus Labs Ltd | Pharmaceuticals | 0.26% |
| Sumitomo Chemical India Ltd | Agro Chemicals | 0.26% |
| Bosch Ltd | Auto Ancillaries | 0.26% |
| Craftsman Automation Ltd | Auto Ancillaries | 0.25% |
| One 97 Communications Ltd | E-Commerce/App based Aggregator | 0.25% |
| Glenmark Pharmaceuticals Ltd | Pharmaceuticals | 0.25% |
Compare against Index Fund category average
This comparison shows how the fund performs relative to the Index Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Index Fund category
| Fund Name | NAV | 1M | 3M | 6M |
|---|---|---|---|---|
| Invesco India Nifty G-sec Sep 2032 Index Fund-Dir (IDCW) | ₹1233.29 | -0.46% | 2.98% | 6.17% |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Dir (G) | ₹1233.29 | -0.46% | 2.98% | 6.17% |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Reg (G) | ₹1229.16 | -0.47% | 2.94% | 6.09% |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Reg (IDCW) | ₹1229.15 | -0.47% | 2.94% | 6.09% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Dir (G) | ₹1199.62 | 0.40% | 2.73% | 4.94% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Dir (IDCW | ₹1199.62 | 0.40% | 2.73% | 4.94% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Reg (IDCW) | ₹1195.53 | 0.38% | 2.69% | 4.86% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Reg (G) | ₹1195.51 | 0.38% | 2.69% | 4.86% |
| HDFC BSE Sensex Index Fund - Direct | ₹790.24 | 3.06% | 10.66% | 7.25% |
| HDFC BSE Sensex Index Fund - Regular | ₹771.61 | 3.04% | 10.61% | 7.17% |
A seasoned investment professional with over 1 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.